文献速递毛发、甲与色素性疾病

Thiamidol有效抑制酪氨酸酶显著改善轻中度黄褐斑

Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma.
PubMed 文献 · J Invest Dermatol · 2019-02-27

该探索性双盲随机分脸研究纳入轻中度黄褐斑女性,比较酪氨酸酶抑制剂Thiamidol与氢醌的疗效。12周后,Thiamidol侧改良MASI评分改善显著优于氢醌侧,且改善受试者比例更高(79% vs 61%)。Thiamidol耐受性良好,未出现评分恶化,而氢醌侧约10%受试者评分恶化。

要点

  • Thiamidol改善轻中度黄褐斑优于氢醌,12周时改良MASI评分显著更优。
  • Thiamidol组79%受试者改善,氢醌组61%,且Thiamidol组无恶化。
  • 所有受试者常规使用防晒,低和高紫外线环境下结果一致。

核心结论

  • Thiamidol是减少色素沉着的有效药物,对轻中度黄褐斑的疗效优于氢醌。

研究设计与样本

  • 探索性双盲、随机、分脸对照研究,纳入轻中度黄褐斑女性,比较Thiamidol与氢醌。

主要发现

  • 12周后,Thiamidol侧和氢醌侧改良MASI评分均显著改善。
  • Thiamidol侧改良MASI评分改善显著优于氢醌侧。
  • Thiamidol组79%受试者改善,氢醌组61%。
  • Thiamidol侧无受试者改良MASI评分恶化,氢醌侧约10%受试者恶化。
  • 受试者评价Thiamidol在整体暗斑强度下降和整体外观方面显著更好。

关键数值与推荐

  • 12周时Thiamidol组79%受试者改善,氢醌组61%。
  • 氢醌侧约10%受试者改良MASI评分恶化,Thiamidol侧无恶化。

临床怎么用

  • Thiamidol可作为轻中度黄褐斑的有效治疗选择,需配合防晒。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Melasma is a pigmentary disorder characterized by hyperpigmented patchy skin in sun-exposed areas, especially the face. Treatment of melasma can be challenging because long-term therapy is required, reoccurrence is common, and existing therapies are insufficient and unsatisfactory. To investigate new treatment options, we performed an exploratory double-blinded, randomized split-face study to assess the efficacy of the tyrosinase inhibitor Thiamidol compared to hydroquinone in women with mild to moderate melasma. After 12 weeks, modified Melasma Area and Severity Index scores significantly improved on both the Thiamidol-treated and the hydroquinone-treated sides of the face. Additionally, Thiamidol treatment improved modified Melasma Area and Severity Index scores significantly better than hydroquinone, and more subjects improved following treatment with Thiamidol (79%) compared with hydroquinone (61%). During treatment, no subjects displayed worsening of modified Melasma Area and Severity Index scores on the Thiamidol-treated side, while approximately 10% of the subjects showed a worsening of modified Melasma Area and Severity Index scores on the hydroquinone-treated side. All subjects routinely used sunscreens and consistent results were obtained in low and in high UV ambient conditions. Subjects rated the efficacy of the Thiamidol formulation significantly better with regard to overall decreased intensity of dark spots and their overall appearance throughout the study. Thiamidol was well-tolerated and well-perceived and represents an effective agent to reduce hyperpigmentation.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Arrowitz C, Schoelermann AM, Mann T, et al. Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma. J Invest Dermatol. 2019. PMID: 30825454. doi:10.1016/j.jid.2019.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。